Tumor Molecular Testing Guides Anti-PD-1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair Variants
Shyam A. Patel(UMass Memorial Health Care), Sigurdís Haraldsdóttir(Stanford University), Alexandra Lebensohn(National Institutes of Health), Albert Y. Lin(National Cancer Institute), Teri A. Longacre(Palo Alto University), Uri Ladabaum(Stanford University)
Cited by 8
Related Papers
Localization of the gene for Cowden disease to chromosome 10q22–23
|Nature Genetics|1996|670
Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
|Journal of Clinical Oncology|2014|486
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
|The Lancet Oncology|2013|434
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019
|Journal of the National Comprehensive Cancer Network|2019|342
Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk
|Genetics in Medicine|2017|219